BACKGROUND: The relationship between electrocardiographic unrecognized myocardial infarction (UMI), abnormal functional status, echocardiographic abnormalities, and mortality has not been evaluated. METHODS: A population-based random sample of 2042 Olmsted County residents, age > or = 45 years, was studied by self-administered questionnaire, chart review, ECG and echocardiogram, and 5 year follow-up for all-cause mortality. UMI (n = 81) was diagnosed if ECG-MI criteria were met without previous documented myocardial infarction. Functional Status was assessed by the Goldman Specific Activity Scale. RESULTS: UMI subjects had an increased prevalence of abnormal functional status compared to no MI controls (22% vs 11%, P < 0.05). This association was independent of sex, obesity, smoking, diabetes, and pulmonary disease. It became insignificant after stratifying for echocardiographic abnormalities. Compared to no MI controls, UMI subjects with impaired functional status had a higher mortality hazard ratio (HR 7.2; P<0.0001) than those without impaired functional status (HR 2.7; P = 0.02). In UMI subjects with impaired functional status and any echocardiographic abnormality signifying global ventricular dysfunction (systolic or diastolic dysfunction, left atrial or left ventricular enlargement), the mortality risk was even higher (HR 9.5; P<0.001) and persisted in multivariate analyses. This increased mortality risk was unaffected by adjustment for regional wall motion abnormalities. CONCLUSIONS: The assessment of impaired functional status and echocardiographic abnormalities improves the prognostic significance of UMI. Even in the absence of regional wall motion abnormalities, structural abnormalities of global dysfunction may play a role in mediating the increased mortality associated with UMI.
BACKGROUND: The relationship between electrocardiographic unrecognized myocardial infarction (UMI), abnormal functional status, echocardiographic abnormalities, and mortality has not been evaluated. METHODS: A population-based random sample of 2042 Olmsted County residents, age > or = 45 years, was studied by self-administered questionnaire, chart review, ECG and echocardiogram, and 5 year follow-up for all-cause mortality. UMI (n = 81) was diagnosed if ECG-MI criteria were met without previous documented myocardial infarction. Functional Status was assessed by the Goldman Specific Activity Scale. RESULTS: UMI subjects had an increased prevalence of abnormal functional status compared to no MI controls (22% vs 11%, P < 0.05). This association was independent of sex, obesity, smoking, diabetes, and pulmonary disease. It became insignificant after stratifying for echocardiographic abnormalities. Compared to no MI controls, UMI subjects with impaired functional status had a higher mortality hazard ratio (HR 7.2; P<0.0001) than those without impaired functional status (HR 2.7; P = 0.02). In UMI subjects with impaired functional status and any echocardiographic abnormality signifying global ventricular dysfunction (systolic or diastolic dysfunction, left atrial or left ventricular enlargement), the mortality risk was even higher (HR 9.5; P<0.001) and persisted in multivariate analyses. This increased mortality risk was unaffected by adjustment for regional wall motion abnormalities. CONCLUSIONS: The assessment of impaired functional status and echocardiographic abnormalities improves the prognostic significance of UMI. Even in the absence of regional wall motion abnormalities, structural abnormalities of global dysfunction may play a role in mediating the increased mortality associated with UMI.
Authors: M C de Bruyne; A Mosterd; A W Hoes; J A Kors; D A Kruijssen; J H van Bemmel; A Hofman; D E Grobbee Journal: Epidemiology Date: 1997-09 Impact factor: 4.822
Authors: Khawaja Afzal Ammar; Barbara P Yawn; Lynn Urban; Douglas W Mahoney; Jan A Kors; Steven Jacobsen; Richard J Rodeheffer Journal: Ann Noninvasive Electrocardiol Date: 2005-04 Impact factor: 1.468
Authors: Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett Journal: J Am Coll Cardiol Date: 2002-09-04 Impact factor: 24.094
Authors: Steven J Jacobsen; Douglas W Mahoney; Margaret M Redfield; Kent R Bailey; John C Burnett; Richard J Rodeheffer Journal: Ann Epidemiol Date: 2004-09 Impact factor: 3.797
Authors: Lori L Boland; Aaron R Folsom; Paul D Sorlie; Herman A Taylor; Wayne D Rosamond; Lloyd E Chambless; Lawton S Cooper Journal: Am J Cardiol Date: 2002-11-01 Impact factor: 2.778
Authors: Holli A DeVon; Glorieuse Uwizeye; Hui Yan Cai; Adhir R Shroff; Joan E Briller; Amer Ardati; Debra Hoppensteadt; Lauren Rountree; Judith M Schlaeger Journal: Acupunct Med Date: 2021-12-02 Impact factor: 2.267
Authors: Andrea Milde Øhrn; Christopher Sivert Nielsen; Henrik Schirmer; Audun Stubhaug; Tom Wilsgaard; Haakon Lindekleiv Journal: J Am Heart Assoc Date: 2016-12-21 Impact factor: 5.501